Crane v. Johnson & Johnson

CourtDistrict Court, E.D. Louisiana
DecidedDecember 4, 2020
Docket2:20-cv-01018
StatusUnknown

This text of Crane v. Johnson & Johnson (Crane v. Johnson & Johnson) is published on Counsel Stack Legal Research, covering District Court, E.D. Louisiana primary law. Counsel Stack provides free access to over 12 million legal documents including statutes, case law, regulations, and constitutions.

Bluebook
Crane v. Johnson & Johnson, (E.D. La. 2020).

Opinion

UNITED STATES DISTRICT COURT EASTERN DISTRICT OF LOUISIANA

LISA CRANE CIVIL ACTION

VER SUS NO. 20-1018

JOHNSON & JOHNSON, et al SECTION “G”(1)

ORDER AND REASONS

Pending before the Court is Defendants Johnson & Johnson and Ethicon, Inc.’s (“Defendants”) “Motion to Dismiss Plaintiff’s Complaint for Untimely Service of Process.”1 In this litigation, Plaintiff Lisa Crane (“Plaintiff”) alleges that Defendants designed, manufactured, and sold a defective medical product that was implanted in Plaintiff, leading to Plaintiff’s injuries.2 In the instant motion, Defendants argue that Plaintiff’s claims should be dismissed because service of process was untimely.3 Considering the motion, the memoranda in support and opposition, and the applicable law, the Court denies the motion. I. Background On March 26, 2020, Plaintiff filed a Complaint in this Court naming Johnson & Johnson, Ethicon, Inc. (“Ethicon”), and Gynecare Inc. (“Gynecare”)4 as defendants.5 According to the Complaint, the companies made, marketed, and sold Prolift, a mesh used to “correct[] vaginal

1 Rec. Doc. 14. 2 Rec. Doc. 1. 3 Rec. Doc. 14. 4 Defendants claim that Gynecare has not existed as a separate entity since January 2000, and, accordingly, is not a proper defendant in this action. 5 Rec. Doc. 1. prolapse, stress urinary incontinence, pelvic organ prolapse and/or rectocele.”6 Plaintiff claims that Prolift was implanted in Plaintiff and that, as a result of the implantation, Plaintiff suffered “significant pain, internal adhesion, and tissue erosion and complications which required surgery to remove the Prolift system and repair damage it caused.”7 Plaintiff alleges that Defendants knew Prolift had adverse side effects.8 Plaintiff claims that

Defendants “suppressed this information” while also “fail[ing] to accurately and completely disseminate or share this and other critical information with the FDA, health care providers, and the patients.”9 Plaintiff argues that Defendants, in fact, did the opposite, “misrepresent[ing] to the Plaintiff, her physicians, and to the medical community at large, that its product had been properly cleared for marketing by the FDA when in fact no such clearance had been sought or obtained.”10 Plaintiff claims that Defendants used “reports, press releases, advertising campaigns, television commercials, print advertisements, billboards and other commercial media” to make these misrepresentations and to sell Prolift.11 Plaintiff brings the following claims against Defendants under Louisiana law: (1) Prolift

was defectively designed; (2) Prolift was defectively manufactured; (3) Defendants failed to warn Plaintiff of the risks of Prolift; and (4) Defendants breached an express warranty when they sold Prolift.12

6 Id. at 5. 7 Id. at 10. 8 Id. at 11. 9 Id. at 12. 10 Id. at 13. 11 Id. at 16. 12 Id. On June 26, 2020, after Plaintiff failed to effectuate timely service, the Court issued an Order to Show Cause.13 On July 21, 2020, Plaintiff’s counsel sent summons to Defendants via email.14 On July 29, 2020, Plaintiff filed a response to the Order to Show Cause, claiming to have served Defendants and seeking additional time to wait for an appearance or to attempt to re-serve each defendant.15 On October 2, 2020, the Court issued a second Order to Show Cause, noting that

the record showed that Ethicon had been served but that Johnson & Johnson and Gynecare had not been served properly.16 On October 16, 2020, counsel for Defendants filed a Notice of Special Appearance.17 Defendants filed the instant motion on October 23, 2020.18 Plaintiff filed an opposition on November 10, 2020.19 Defendants, with leave of Court, filed a reply in further support of the motion on November 16, 2020.20 Plaintiff, with leave of Court, filed a sur-reply on November 18, 2020.21 On December 2, 2020, the Court held oral argument on the motion.22 II. Parties’ Arguments A. Defendants’ Arguments in Support of the Motion

Defendants argue that Plaintiff was “unjustified” in failing to serve Defendants within 90

13 Rec. Doc. 4. 14 Rec Doc. 8; Rec. Doc. 9; Rec. Doc. 10. 15 Rec. Doc. 11. 16 Rec. Doc. 12. 17 Rec. Doc. 13. 18 Rec. Doc. 14. 19 Rec. Doc. 16. 20 Rec. Doc. 20. 21 Rec. Doc. 24. 22 Rec. Doc. 21. days of filing the Complaint, as required by Federal Rule of Civil Procedure 4(m).23 Defendants assert that this Court can extend the time for service only if Plaintiff can show good cause for her failure to properly serve Defendants.24 Defendants argue that Plaintiff cannot show good cause for the delay and, accordingly, this Court should dismiss Plaintiff’s claims against Defendants.25

Defendants contend that “the record . . . reflects that Plaintiff actually made no effort to serve Defendants until after the deadline had already expired.”26 Defendants assert that Plaintiff failed to make any attempt to serve Defendants prior to this Court’s Order to Show Cause, issued on June 26, 2020, which was two days after the deadline for service of process had expired.27 Even when Plaintiff did begin “her efforts to communicate with Defendants regarding service of process,” Defendants allege, Plaintiff’s counsel still did not “attempt service.”28 Instead, Defendants assert that Plaintiff’s counsel sent incomplete forms for waiving formal service and sent Ethicon’s documents to the wrong address.29 Moreover, Defendants argue that Gynecare ceased to exist as a separate entity in January 2000, so Plaintiff’s “alleged attempt at ‘service’ in June 2020 was not actually an effective means of service under Rule 4 and should not have been considered as such by Plaintiff.”30

Defendants further allege that Plaintiff has failed to offer any excuse for the untimely

23 Rec. Doc. 14-1 at 9. 24 Id. 25 Id. 26 Id. 27 Id. at 10. 28 Id. 29 Id. 30 Id. at 10–11. service.31 Defendants contend that “Plaintiff generally discussed business and governmental closures caused by the COVID-19 pandemic” in Plaintiff’s response to the Order to Show Cause, but Defendants assert that the deadline to effect service of process was not impacted by any emergency COVID-19 orders.32 Defendants argue that “the record reflects that Plaintiff’s failure

to effectuate timely service was due to simple inattention to Rule 4(m), coupled with an apparent misunderstanding of the requirements and legal effect of a request for waiver of service under Rule 4(d).”33 Defendants contend that these reasons for untimely service do not rise to the level of good cause necessary to excuse Plaintiff’s delay.34 Defendants argue that, even if granting dismissal would mean that Plaintiff would be time-barred from re-filing this action, this Court should “disregard that argument,” because to do otherwise would be “granting Plaintiff a de facto extension of the statute of limitations while forcing Defendants to litigate a case that—under a clear reading of the text of Rule 4(m)—they would expect to be dismissed.”35 B. Plaintiff’s Arguments in Opposition to the Motion Plaintiff responds to the motion by making three main arguments. First, Plaintiff argues that there is good cause to excuse her failure to effectuate timely service on Defendants.36 Plaintiff

points to the COVID-19 pandemic, which caused Defendants’ offices to close and Plaintiff’s counsel’s office to switch to remote work, as evidence of good cause for delay.37 Second, Plaintiff

31 Id. at 11. 32 Id. at 10. 33 Id. at 11. 34 Id. 35 Id. at 11–12. 36 Rec. Doc. 16 at 2. 37 Id. at 2–6.

Free access — add to your briefcase to read the full text and ask questions with AI

Related

McGinnis v. Shalala
2 F.3d 548 (Fifth Circuit, 1993)
Newby v. Enron Corp.
284 F. App'x 146 (Fifth Circuit, 2008)
Gartin v. Par Pharmaceutical Co.
289 F. App'x 688 (Fifth Circuit, 2008)
Ronald Lambert v. United States
44 F.3d 296 (Fifth Circuit, 1995)
Brandon Thrasher v. Amarillo Police Dept
709 F.3d 509 (Fifth Circuit, 2013)

Cite This Page — Counsel Stack

Bluebook (online)
Crane v. Johnson & Johnson, Counsel Stack Legal Research, https://law.counselstack.com/opinion/crane-v-johnson-johnson-laed-2020.